Jersey Shore Ready ...
Health Care: Drugs
Ligand Pharmaceuticals Inc. (LGND: NASDAQ)
$27.47 -0.48 | -1.72%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -527.00K | 10.18M | -10.37M | -1.95M |
| Operating Gains/Losses | 0.00 | -450.00K | -607.00K | -232.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.52M | -3.92M | -375.00K | -618.00K |
| (Increase) Decrease in Inventories | 1.03M | 1.11M | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 515.00K | 4.86M | -3.93M | -448.00K |
| (Decrease) Increase In Payables | -4.80M | -11.57M | -13.45M | -10.99M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -1.03M | 3.63M | -6.98M | -6.27M |
| Other Non-Cash Items | 2.83M | 5.44M | 896.00K | -15.26M |
| Net Cash From Continuing Operations | 1.06M | -1.17M | -27.31M | -30.64M |
| Net Cash From Discontinued Operations | -900.00K | 0.00 | 240.00K | -3.16M |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 161.00K | -1.17M | -27.07M | -33.80M |
| Sale of Property, Plant & Equipment | 20.00K | 530.00K | 589.00K | 108.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 10.00M | 19.35M | 54.04M | 47.76M |
| Purchases of Property, Plant & Equipment | -595.00K | -78.00K | -70.00K | -522.00K |
| Acquisitions | 0.00 | -32.02M | 0.00 | 9.80M |
| Purchases of Short-Term Investments | 0.00 | -10.00M | -35.58M | -32.81M |
| Other Cash from Investing Activities | -8.16M | -2.91M | -4.44M | 431.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 1.26M | -25.13M | 14.54M | 24.77M |
| Issuance of Debt | 7.50M | 30.05M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 6.42M | 0.00 | 23.00K | 228.00K |
| Repayment of Long-Term Debt | -10.00M | 0.00 | -91.00K | -3.92M |
| Repurchase of Capital Stock | 0.00 | -55.00K | -91.00K | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 3.92M | 30.00M | -159.00K | -3.69M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 5.34M | 3.70M | -12.69M | -12.72M |
Portfolios with LGND
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 6
- ContributorStocks With Big Insider Buy...
- Contributor8 Stocks With Substantial I...
Latest LGND Headlines from TheStreet
- Ligand Pharmaceuticals Inc. Stock Upgraded (LGND) 05.15.13 | 05:05 am
- Ligand Pharmaceuticals Inc. Stock Downgraded (LGND) 02.18.13 | 04:02 am
- 5 Hated Stocks Set to Soar on Earnings 02.12.13 | 12:02 pm
- 5 Stocks Insiders Are Scooping Up 01.30.13 | 12:01 pm
- Top Insider Trades: BAC LGND PCRX BDBD 01.28.13 | 08:01 am
- 7 Stocks Rising on Unusual Volume 01.09.13 | 02:01 pm
- The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
11.30.12 | 05:11 am - 6 Stocks Rising on Unusual Volume 11.19.12 | 03:11 pm
- Stocks Under $10: Blossoming Biotech Play 09.25.12 | 06:09 am
- Onyx's Kyprolis Cancer Drug Approved 07.20.12 | 12:07 pm
Press Releases for LGND
- Ligand Signs Global License Agreement With Spectrum Pharmaceuticals For Captisol-Enabled® Melphalan - Business Wire 03.14.13 | 07:03 am
- Ligand Receives $1.4 Million Milestone Payment From Retrophin, Inc. - Business Wire 02.25.13 | 09:02 am
- Ligand Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.13.13 | 04:02 pm
- Ligand To Report Fourth Quarter Results On February 13th - Business Wire 01.23.13 | 09:01 am
- Ligand Receives Equity Milestone Payment From Retrophin - Business Wire 01.09.13 | 09:01 am
- U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteoporosis - Business Wire 12.13.12 | 05:12 pm
- U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteoporosis - Business Wire 12.13.12 | 05:12 pm
- Ligand Initiates Pivotal Trial Of Captisol-Enabled®, Propylene Glycol-Free Melphalan In Patients With Multiple Myeloma - Business Wire 12.10.12 | 04:12 pm
- Ligand To Present Growth Prospects, Review Key Portfolio Assets And Introduce Financial Guidance At Analyst Day Event - Business Wire 12.04.12 | 08:12 am
- Reminder: Ligand To Host Analyst Day On December 4th In New York City - Business Wire 11.27.12 | 09:11 am
Partner Headlines for LGND
- Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication - Benzinga 11.19.12 | 09:11 am
- Ligand Pharma Announces Preclinical Data for LG-7501 - Benzinga 11.13.12 | 09:11 am
- The Medicines Co. Halts MDCO-2010 - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Netflix REITERATED Below Average and 3 Analyst-Reiterated Ratings Starting the Week - Wall St. Cheat Sheet 07.23.12 | 04:07 am
- DJIA Weekly Review: Back-to-School Forecast Warms Up, GE and Chevron Craft Deal - Wall St. Cheat Sheet 07.22.12 | 10:07 am
- Healthcare Business Recap: Onyx's Drug Gets APPROVED, Somaxon DIVESTS Shares - Wall St. Cheat Sheet 07.20.12 | 11:07 am
- Pfizer Review ACCEPTED and 4 Stocks Enjoying 52-Week Highs - Wall St. Cheat Sheet 07.20.12 | 09:07 am
- 3M SETTLES Suit and 3 Dow Movers to Watch - Wall St. Cheat Sheet 07.19.12 | 05:07 am
- Jim Cramer Calls: Sell HP and 'Buy, Buy, Buy' These Hot Stocks Now - Wall St. Cheat Sheet 07.16.12 | 10:07 am
